Our study showsthat blockingactivin signalingreduces ______production.Which type of assayis used to evaluateNO levels in ourstudy: fluorometricor colorimetric? _____________"In our experiments,the reduction inoxidative stress wasmeasured as adecrease in the foldchange of ______.Follistatintreatment induces______ of PVAT, aphenotypeassociated withimproved vascularfunction.Follistatin isknown toneutralizesignaling by______.Hypertension isdefined bysustained bloodpressure above____ mmHg.FST’santioxidanteffect is lostif it is______.The fluorescentproductproduced in theAmplexRedassay is called______.Follistatinretains itsantioxidanteffect evenwhen denatured.True/FalseFST lowersROS levels, asindicated by adecrease in______ levels.FST wasadministeredevery______ day.In our study,follistatin wasadministered toSHRs over aperiod of______ weeks.Neutralizingantibodiestargetedactivin A and______.Follistatintreatmentreduced bloodpressure byapproximately______ mmHg.Follistatinincreases theexpression of______, which iscritical for nitricoxide production.Which proteinmarker indicatesa brown adiposephenotype inPVAT?_____________What does theabbreviation'SHR' stand for? _____________Our assaydirectlymeasureshydrogen______ levels.What assay didwe use toquantifyhydrogenperoxide?_____________Follistatinmust maintainits proper______ to befunctional.Whichhypertensiveanimal modeldid we use?___________Enhanced NObioavailabilityindicatesimproved______.Whichnormotensivestrain served asour control?_____________What is theendogenousprotein we studiedthat antagonizesactivin?_____________Our study showsthat blockingactivin signalingreduces ______production.Which type of assayis used to evaluateNO levels in ourstudy: fluorometricor colorimetric? _____________"In our experiments,the reduction inoxidative stress wasmeasured as adecrease in the foldchange of ______.Follistatintreatment induces______ of PVAT, aphenotypeassociated withimproved vascularfunction.Follistatin isknown toneutralizesignaling by______.Hypertension isdefined bysustained bloodpressure above____ mmHg.FST’santioxidanteffect is lostif it is______.The fluorescentproductproduced in theAmplexRedassay is called______.Follistatinretains itsantioxidanteffect evenwhen denatured.True/FalseFST lowersROS levels, asindicated by adecrease in______ levels.FST wasadministeredevery______ day.In our study,follistatin wasadministered toSHRs over aperiod of______ weeks.Neutralizingantibodiestargetedactivin A and______.Follistatintreatmentreduced bloodpressure byapproximately______ mmHg.Follistatinincreases theexpression of______, which iscritical for nitricoxide production.Which proteinmarker indicatesa brown adiposephenotype inPVAT?_____________What does theabbreviation'SHR' stand for? _____________Our assaydirectlymeasureshydrogen______ levels.What assay didwe use toquantifyhydrogenperoxide?_____________Follistatinmust maintainits proper______ to befunctional.Whichhypertensiveanimal modeldid we use?___________Enhanced NObioavailabilityindicatesimproved______.Whichnormotensivestrain served asour control?_____________What is theendogenousprotein we studiedthat antagonizesactivin?_____________

Follistatin to the Rescue: Bingo for Lowering Pressure and Defeating ROS - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
  1. Our study shows that blocking activin signaling reduces ______ production.
  2. Which type of assay is used to evaluate NO levels in our study: fluorometric or colorimetric? _____________
  3. "In our experiments, the reduction in oxidative stress was measured as a decrease in the fold change of ______.
  4. Follistatin treatment induces ______ of PVAT, a phenotype associated with improved vascular function.
  5. Follistatin is known to neutralize signaling by ______.
  6. Hypertension is defined by sustained blood pressure above ____ mmHg.
  7. FST’s antioxidant effect is lost if it is ______.
  8. The fluorescent product produced in the AmplexRed assay is called ______.
  9. Follistatin retains its antioxidant effect even when denatured. True/False
  10. FST lowers ROS levels, as indicated by a decrease in ______ levels.
  11. FST was administered every ______ day.
  12. In our study, follistatin was administered to SHRs over a period of ______ weeks.
  13. Neutralizing antibodies targeted activin A and ______.
  14. Follistatin treatment reduced blood pressure by approximately ______ mmHg.
  15. Follistatin increases the expression of ______, which is critical for nitric oxide production.
  16. Which protein marker indicates a brown adipose phenotype in PVAT? _____________
  17. What does the abbreviation 'SHR' stand for? _____________
  18. Our assay directly measures hydrogen ______ levels.
  19. What assay did we use to quantify hydrogen peroxide? _____________
  20. Follistatin must maintain its proper ______ to be functional.
  21. Which hypertensive animal model did we use? ___________
  22. Enhanced NO bioavailability indicates improved ______.
  23. Which normotensive strain served as our control? _____________
  24. What is the endogenous protein we studied that antagonizes activin? _____________